Search

21 Sep 2015: Quethera: A new vision for gene therapy. Share:. We recently announced a new investment in Quethera, a gene therapy company that focuses on treatments for glaucoma. ... tried them all), the news represents an interesting development in the use of gene

17 Aug 2015: new businesses take shape. ... out. Now we have more exciting news – we’re expanding. Not through the over-indulgence of cake — although that is one of our favourite pastimes — but by growing the team to

31 Aug 2015: I’m not sure our companies find it much fun either. But the exercise is vital, allowing us to demonstrate the impact generated by the University through its support for new

1 Dec 2015: Cambridge Enterprise has been commercialising reagents derived from University research for a decade.

16 Dec 2015: Cambridge Enterprise provided initial seed funding and guidance to Jukedeck. When the company needed further funds in 2014, it was introduced to CIC.

15 Sep 2015: From Westminster to West Cambridge. Share:. When I started at Cambridge Enterprise in the spring I assumed, not unsurprisingly, that all of my new colleagues would have backgrounds in science.

30 Jul 2015: To that end, Cambridge Enterprise and the Entrepreneurial Postdocs of Cambridge (EPOC) are launching a new business plan competition aimed at helping University postdocs successfully commercialise their ideas.

2 Nov 2015: Postdocs: interested in learning more about commercialisation of University research? Come along to our event on 19 November. Read more here.

14 Oct 2015: Blog: Preference shares are pervasive throughout the investment community. Investors expect them and companies accept them. Cambridge Enterprise's Bradley Hardiman explains.

11 Aug 2015: As new inventions from the laboratory were disclosed to Cambridge Enterprise, DefiniGEN was the natural choice to approach to take on additional licences. ... Today DefiniGEN stands as an example that companies need not have contractual relationship with